Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program.

PubWeight™: 7.99‹?› | Rank: Top 0.1%

🔗 View Article (PMC 2194188)

Published in J Exp Med on September 01, 2003

Authors

Martin I Voskuil1, Dirk Schnappinger, Kevin C Visconti, Maria I Harrell, Gregory M Dolganov, David R Sherman, Gary K Schoolnik

Author Affiliations

1: Beckman Center, Rm. 241, Stanford Medical School, Stanford, CA 94305, USA.

Articles citing this

(truncated to the top 100)

Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages: Insights into the Phagosomal Environment. J Exp Med (2003) 10.67

The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol (2009) 8.13

High functional diversity in Mycobacterium tuberculosis driven by genetic drift and human demography. PLoS Biol (2008) 4.74

Genome-wide requirements for Mycobacterium tuberculosis adaptation and survival in macrophages. Proc Natl Acad Sci U S A (2005) 4.43

A multistage tuberculosis vaccine that confers efficient protection before and after exposure. Nat Med (2011) 4.09

The enduring hypoxic response of Mycobacterium tuberculosis. PLoS One (2008) 3.87

The Vibrio cholerae chitin utilization program. Proc Natl Acad Sci U S A (2004) 3.51

Progression to active tuberculosis, but not transmission, varies by Mycobacterium tuberculosis lineage in The Gambia. J Infect Dis (2008) 3.15

Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS Pathog (2008) 3.02

Comprehensive functional analysis of Mycobacterium tuberculosis toxin-antitoxin systems: implications for pathogenesis, stress responses, and evolution. PLoS Genet (2009) 2.89

Changes in energy metabolism of Mycobacterium tuberculosis in mouse lung and under in vitro conditions affecting aerobic respiration. Proc Natl Acad Sci U S A (2005) 2.84

Two sensor kinases contribute to the hypoxic response of Mycobacterium tuberculosis. J Biol Chem (2004) 2.71

Mycobacterium tuberculosis DosS is a redox sensor and DosT is a hypoxia sensor. Proc Natl Acad Sci U S A (2007) 2.55

Induction of a novel class of diacylglycerol acyltransferases and triacylglycerol accumulation in Mycobacterium tuberculosis as it goes into a dormancy-like state in culture. J Bacteriol (2004) 2.51

Dormancy phenotype displayed by extracellular Mycobacterium tuberculosis within artificial granulomas in mice. J Exp Med (2004) 2.46

The W-Beijing lineage of Mycobacterium tuberculosis overproduces triglycerides and has the DosR dormancy regulon constitutively upregulated. J Bacteriol (2007) 2.42

Selective killing of nonreplicating mycobacteria. Cell Host Microbe (2008) 2.39

The peptidoglycan of stationary-phase Mycobacterium tuberculosis predominantly contains cross-links generated by L,D-transpeptidation. J Bacteriol (2008) 2.39

Growth of Mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug-tolerant bacteria. Mol Microbiol (2008) 2.35

The immunological life cycle of tuberculosis. Nat Rev Immunol (2012) 2.25

Mycobacterium tuberculosis senses host-derived carbon monoxide during macrophage infection. Cell Host Microbe (2008) 2.24

A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogen. PLoS One (2009) 2.15

Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs. Proc Natl Acad Sci U S A (2005) 2.06

Functional genetic diversity among Mycobacterium tuberculosis complex clinical isolates: delineation of conserved core and lineage-specific transcriptomes during intracellular survival. PLoS Pathog (2010) 2.06

Sigma factors and global gene regulation in Mycobacterium tuberculosis. J Bacteriol (2004) 2.05

Heme oxygenase-1-derived carbon monoxide induces the Mycobacterium tuberculosis dormancy regulon. J Biol Chem (2008) 2.04

Why is long-term therapy required to cure tuberculosis? PLoS Med (2007) 2.03

Bacterial growth and cell division: a mycobacterial perspective. Microbiol Mol Biol Rev (2008) 2.01

Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosis. Clin Vaccine Immunol (2006) 1.99

Stationary phase gene expression of Mycobacterium tuberculosis following a progressive nutrient depletion: a model for persistent organisms? Tuberculosis (Edinb) (2004) 1.92

Probing host pathogen cross-talk by transcriptional profiling of both Mycobacterium tuberculosis and infected human dendritic cells and macrophages. PLoS One (2008) 1.91

The Mycobacterium tuberculosis protein LdtMt2 is a nonclassical transpeptidase required for virulence and resistance to amoxicillin. Nat Med (2010) 1.91

Biosynthesis and functions of mycothiol, the unique protective thiol of Actinobacteria. Microbiol Mol Biol Rev (2008) 1.88

Sequence-based analysis uncovers an abundance of non-coding RNA in the total transcriptome of Mycobacterium tuberculosis. PLoS Pathog (2011) 1.83

Tuberculosis chemotherapy: the influence of bacillary stress and damage response pathways on drug efficacy. Clin Microbiol Rev (2006) 1.82

Prominent roles of the NorR and Fur regulators in the Escherichia coli transcriptional response to reactive nitrogen species. Proc Natl Acad Sci U S A (2004) 1.81

PhoP: a missing piece in the intricate puzzle of Mycobacterium tuberculosis virulence. PLoS One (2008) 1.79

The Mycobacterium tuberculosis DosR regulon assists in metabolic homeostasis and enables rapid recovery from nonrespiring dormancy. J Bacteriol (2009) 1.75

Self-poisoning of Mycobacterium tuberculosis by targeting GlgE in an alpha-glucan pathway. Nat Chem Biol (2010) 1.72

Basic concepts of microarrays and potential applications in clinical microbiology. Clin Microbiol Rev (2009) 1.70

Mycobacterium tuberculosis WhiB3 responds to O2 and nitric oxide via its [4Fe-4S] cluster and is essential for nutrient starvation survival. Proc Natl Acad Sci U S A (2007) 1.70

Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa. Clin Vaccine Immunol (2009) 1.67

Global transcriptional profile of Mycobacterium tuberculosis during THP-1 human macrophage infection. Infect Immun (2007) 1.66

Identification of a diacylglycerol acyltransferase gene involved in accumulation of triacylglycerol in Mycobacterium tuberculosis under stress. Microbiology (2006) 1.66

Virulence factors of the Mycobacterium tuberculosis complex. Virulence (2012) 1.64

Characterization and transcriptome analysis of Mycobacterium tuberculosis persisters. MBio (2011) 1.64

Immunogenicity of eight dormancy regulon-encoded proteins of Mycobacterium tuberculosis in DNA-vaccinated and tuberculosis-infected mice. Infect Immun (2006) 1.63

Role of the dosR-dosS two-component regulatory system in Mycobacterium tuberculosis virulence in three animal models. Infect Immun (2008) 1.63

Biosynthesis and recycling of nicotinamide cofactors in mycobacterium tuberculosis. An essential role for NAD in nonreplicating bacilli. J Biol Chem (2008) 1.62

Role of narK2X and narGHJI in hypoxic upregulation of nitrate reduction by Mycobacterium tuberculosis. J Bacteriol (2003) 1.58

The temporal response of the Mycobacterium tuberculosis gene regulatory network during growth arrest. Mol Syst Biol (2008) 1.56

Prioritizing genomic drug targets in pathogens: application to Mycobacterium tuberculosis. PLoS Comput Biol (2006) 1.53

The response of mycobacterium tuberculosis to reactive oxygen and nitrogen species. Front Microbiol (2011) 1.53

Identification of a small molecule with activity against drug-resistant and persistent tuberculosis. Proc Natl Acad Sci U S A (2013) 1.51

DosT and DevS are oxygen-switched kinases in Mycobacterium tuberculosis. Protein Sci (2007) 1.51

Antibody profiles characteristic of Mycobacterium tuberculosis infection state. Infect Immun (2005) 1.49

Unique flexibility in energy metabolism allows mycobacteria to combat starvation and hypoxia. PLoS One (2010) 1.49

Fumarate reductase activity maintains an energized membrane in anaerobic Mycobacterium tuberculosis. PLoS Pathog (2011) 1.45

Transcription regulation by the Mycobacterium tuberculosis alternative sigma factor SigD and its role in virulence. J Bacteriol (2004) 1.45

Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses. Immunol Rev (2015) 1.45

The Mtb proteome library: a resource of assays to quantify the complete proteome of Mycobacterium tuberculosis. Cell Host Microbe (2013) 1.44

T-cell recognition of the HspX protein of Mycobacterium tuberculosis correlates with latent M. tuberculosis infection but not with M. bovis BCG vaccination. Infect Immun (2007) 1.43

Carbon flux rerouting during Mycobacterium tuberculosis growth arrest. Mol Microbiol (2010) 1.43

Use of spoligotyping and large sequence polymorphisms to study the population structure of the Mycobacterium tuberculosis complex in a cohort study of consecutive smear-positive tuberculosis cases in The Gambia. J Clin Microbiol (2009) 1.41

Multifunctional essentiality of succinate metabolism in adaptation to hypoxia in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (2013) 1.41

Expression levels of Mycobacterium tuberculosis antigen-encoding genes versus production levels of antigen-specific T cells during stationary level lung infection in mice. Immunology (2006) 1.41

Mycobacterial bacilli are metabolically active during chronic tuberculosis in murine lungs: insights from genome-wide transcriptional profiling. J Bacteriol (2007) 1.40

Metronidazole lacks activity against Mycobacterium tuberculosis in an in vivo hypoxic granuloma model of latency. J Infect Dis (2008) 1.40

Mycobacterium tuberculosis from chronic murine infections that grows in liquid but not on solid medium. BMC Infect Dis (2004) 1.39

A predicted operon map for Mycobacterium tuberculosis. Nucleic Acids Res (2007) 1.39

A blind deconvolution approach to high-resolution mapping of transcription factor binding sites from ChIP-seq data. Genome Biol (2009) 1.39

Deletion of the Mycobacterium tuberculosis alpha-crystallin-like hspX gene causes increased bacterial growth in vivo. Infect Immun (2006) 1.38

Mycobacterium tuberculosis universal stress protein Rv2623 regulates bacillary growth by ATP-Binding: requirement for establishing chronic persistent infection. PLoS Pathog (2009) 1.37

Central carbon metabolism in Mycobacterium tuberculosis: an unexpected frontier. Trends Microbiol (2011) 1.36

The genome of a pathogenic rhodococcus: cooptive virulence underpinned by key gene acquisitions. PLoS Genet (2010) 1.36

Mycobacterium tuberculosis WhiB1 is an essential DNA-binding protein with a nitric oxide-sensitive iron-sulfur cluster. Biochem J (2010) 1.35

Mycobacterium tuberculosis is able to accumulate and utilize cholesterol. J Bacteriol (2009) 1.35

Function of the cytochrome bc1-aa3 branch of the respiratory network in mycobacteria and network adaptation occurring in response to its disruption. J Bacteriol (2005) 1.33

Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination. Infect Immun (2007) 1.33

Identification of gene targets against dormant phase Mycobacterium tuberculosis infections. BMC Infect Dis (2007) 1.32

Unique roles of DosT and DosS in DosR regulon induction and Mycobacterium tuberculosis dormancy. Infect Immun (2009) 1.32

Redox homeostasis in mycobacteria: the key to tuberculosis control? Expert Rev Mol Med (2011) 1.32

A new unifying theory of the pathogenesis of tuberculosis. Tuberculosis (Edinb) (2013) 1.31

Deletion of the Mycobacterium tuberculosis pknH gene confers a higher bacillary load during the chronic phase of infection in BALB/c mice. J Bacteriol (2005) 1.31

DosS responds to a reduced electron transport system to induce the Mycobacterium tuberculosis DosR regulon. J Bacteriol (2010) 1.30

Phosphodiesterase-4 inhibition alters gene expression and improves isoniazid-mediated clearance of Mycobacterium tuberculosis in rabbit lungs. PLoS Pathog (2011) 1.29

Liver X receptors contribute to the protective immune response against Mycobacterium tuberculosis in mice. J Clin Invest (2009) 1.29

Pathogenesis, immunology, and diagnosis of latent Mycobacterium tuberculosis infection. Clin Dev Immunol (2010) 1.29

Identification and characterization of a regulatory sequence recognized by Mycobacterium tuberculosis persistence regulator MprA. J Bacteriol (2005) 1.27

Identification of Histoplasma capsulatum transcripts induced in response to reactive nitrogen species. Mol Biol Cell (2005) 1.27

Menaquinone synthesis is critical for maintaining mycobacterial viability during exponential growth and recovery from non-replicating persistence. Mol Microbiol (2009) 1.26

Cooperative binding of phosphorylated DevR to upstream sites is necessary and sufficient for activation of the Rv3134c-devRS operon in Mycobacterium tuberculosis: implication in the induction of DevR target genes. J Bacteriol (2008) 1.26

Nitrate enhances the survival of Mycobacterium tuberculosis during inhibition of respiration. J Bacteriol (2008) 1.26

2.3 A X-ray structure of the heme-bound GAF domain of sensory histidine kinase DosT of Mycobacterium tuberculosis. Biochemistry (2008) 1.26

Vaccines for tuberculosis: novel concepts and recent progress. Clin Microbiol Rev (2005) 1.26

Genome sequence of the Fleming strain of Micrococcus luteus, a simple free-living actinobacterium. J Bacteriol (2009) 1.25

DevS, a heme-containing two-component oxygen sensor of Mycobacterium tuberculosis. Biochemistry (2007) 1.24

Physiology of mycobacteria. Adv Microb Physiol (2009) 1.23

Crystal structures of the response regulator DosR from Mycobacterium tuberculosis suggest a helix rearrangement mechanism for phosphorylation activation. J Mol Biol (2008) 1.20

Phosphodiesterase 4 inhibition reduces innate immunity and improves isoniazid clearance of Mycobacterium tuberculosis in the lungs of infected mice. PLoS One (2011) 1.20

Articles cited by this

Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature (1998) 60.62

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA (1999) 27.82

Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature (2000) 11.48

Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages: Insights into the Phagosomal Environment. J Exp Med (2003) 10.67

An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect Immun (1996) 9.21

Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol Microbiol (2002) 8.90

Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha -crystallin. Proc Natl Acad Sci U S A (2001) 7.65

Nonreplicating persistence of mycobacterium tuberculosis. Annu Rev Microbiol (2001) 7.05

Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis. Mol Microbiol (2003) 5.68

Anhydrobiosis. Annu Rev Physiol (1992) 5.37

The Mycobacterium tuberculosis ECF sigma factor sigmaE: role in global gene expression and survival in macrophages. Mol Microbiol (2001) 4.60

ideR, An essential gene in mycobacterium tuberculosis: role of IdeR in iron-dependent gene expression, iron metabolism, and oxidative stress response. Infect Immun (2002) 4.54

Stationary phase-associated protein expression in Mycobacterium tuberculosis: function of the mycobacterial alpha-crystallin homolog. J Bacteriol (1996) 4.05

Expression of Th1-mediated immunity in mouse lungs induces a Mycobacterium tuberculosis transcription pattern characteristic of nonreplicating persistence. Proc Natl Acad Sci U S A (2002) 3.50

Analysis of nitric oxide synthase and nitrotyrosine expression in human pulmonary tuberculosis. Am J Respir Crit Care Med (2002) 3.50

Tuberculosis: latency and reactivation. Infect Immun (2001) 3.15

Nitrosative stress: activation of the transcription factor OxyR. Cell (1996) 3.12

Synchronized replication of Mycobacterium tuberculosis. Infect Immun (1977) 3.12

Mycobacterium bovis BCG response regulator essential for hypoxic dormancy. J Bacteriol (2002) 2.94

Alpha-crystallin-type heat shock proteins: socializing minichaperones in the context of a multichaperone network. Microbiol Mol Biol Rev (2002) 2.80

Characterization of the major membrane protein of virulent Mycobacterium tuberculosis. Infect Immun (1992) 2.61

Reduced replication of Toxoplasma gondii is necessary for induction of bradyzoite-specific antigens: a possible role for nitric oxide in triggering stage conversion. Infect Immun (1994) 2.26

Regulation of mitochondrial respiration by nitric oxide inhibition of cytochrome c oxidase. Biochim Biophys Acta (2001) 2.21

Nitric oxide, nitrite, and Fnr regulation of hmp (flavohemoglobin) gene expression in Escherichia coli K-12. J Bacteriol (1996) 2.02

Nitrate reduction as a marker for hypoxic shiftdown of Mycobacterium tuberculosis. Tuber Lung Dis (1998) 1.99

Truncated hemoglobin HbN protects Mycobacterium bovis from nitric oxide. Proc Natl Acad Sci U S A (2002) 1.94

A novel method of gene transcript profiling in airway biopsy homogenates reveals increased expression of a Na+-K+-Cl- cotransporter (NKCC1) in asthmatic subjects. Genome Res (2001) 1.86

Redox signaling: globalization of gene expression. EMBO J (2000) 1.78

Whole genome DNA microarray expression analysis of biofilm development by Vibrio cholerae O1 E1 Tor. Methods Enzymol (2001) 1.77

Oxygen sensing in yeast: evidence for the involvement of the respiratory chain in regulating the transcription of a subset of hypoxic genes. Proc Natl Acad Sci U S A (1999) 1.70

Response to reactive nitrogen intermediates in Mycobacterium tuberculosis: induction of the 16-kilodalton alpha-crystallin homolog by exposure to nitric oxide donors. Infect Immun (1999) 1.65

The universal stress protein A of Escherichia coli is required for resistance to DNA damaging agents and is regulated by a RecA/FtsK-dependent regulatory pathway. Mol Microbiol (2000) 1.59

Cellular signaling with nitric oxide and cyclic guanosine monophosphate. Semin Perinatol (2000) 1.14

In vitro activities of mitomycin C against growing and hypoxic dormant tubercle bacilli. Antimicrob Agents Chemother (2001) 1.09

Two-stage gene regulation of the superoxide stress response soxRS system in Escherichia coli. Crit Rev Eukaryot Gene Expr (1996) 0.96

Articles by these authors

Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages: Insights into the Phagosomal Environment. J Exp Med (2003) 10.67

The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol (2009) 8.13

Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis. Mol Microbiol (2003) 5.68

The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science (2006) 5.41

Host-induced epidemic spread of the cholera bacterium. Nature (2002) 5.20

Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guérin attenuation. J Infect Dis (2002) 5.15

Chitin induces natural competence in Vibrio cholerae. Science (2005) 5.00

Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat Med (2002) 4.65

Individual RD1-region genes are required for export of ESAT-6/CFP-10 and for virulence of Mycobacterium tuberculosis. Mol Microbiol (2004) 4.62

ideR, An essential gene in mycobacterium tuberculosis: role of IdeR in iron-dependent gene expression, iron metabolism, and oxidative stress response. Infect Immun (2002) 4.54

Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc Natl Acad Sci U S A (2007) 4.21

A multistage tuberculosis vaccine that confers efficient protection before and after exposure. Nat Med (2011) 4.09

Controlling gene expression in mycobacteria with anhydrotetracycline and Tet repressor. Nucleic Acids Res (2005) 4.00

The enduring hypoxic response of Mycobacterium tuberculosis. PLoS One (2008) 3.87

The Vibrio cholerae chitin utilization program. Proc Natl Acad Sci U S A (2004) 3.51

Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas. Clin Cancer Res (2013) 3.25

The secret lives of the pathogenic mycobacteria. Annu Rev Microbiol (2003) 3.15

Tuberculous granuloma formation is enhanced by a mycobacterium virulence determinant. PLoS Biol (2004) 3.12

A membrane protein preserves intrabacterial pH in intraphagosomal Mycobacterium tuberculosis. Nat Med (2008) 2.97

Hyperplasia of smooth muscle in mild to moderate asthma without changes in cell size or gene expression. Am J Respir Crit Care Med (2004) 2.93

In vivo gene silencing identifies the Mycobacterium tuberculosis proteasome as essential for the bacteria to persist in mice. Nat Med (2007) 2.76

Role of the extracytoplasmic-function sigma factor sigma(H) in Mycobacterium tuberculosis global gene expression. Mol Microbiol (2002) 2.73

TB database: an integrated platform for tuberculosis research. Nucleic Acids Res (2008) 2.71

Two sensor kinases contribute to the hypoxic response of Mycobacterium tuberculosis. J Biol Chem (2004) 2.71

Molecular analysis of rugosity in a Vibrio cholerae O1 El Tor phase variant. Mol Microbiol (2004) 2.66

Dissecting asthma using focused transgenic modeling and functional genomics. J Allergy Clin Immunol (2005) 2.65

Gluconeogenic carbon flow of tricarboxylic acid cycle intermediates is critical for Mycobacterium tuberculosis to establish and maintain infection. Proc Natl Acad Sci U S A (2010) 2.62

A replication clock for Mycobacterium tuberculosis. Nat Med (2009) 2.49

Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis. Microbes Infect (2006) 2.33

Ancestral antibiotic resistance in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (2005) 2.21

Mycobacterial survival strategies in the phagosome: defence against host stresses. Cell Microbiol (2009) 2.18

Microarray expression profiling: capturing a genome-wide portrait of the transcriptome. Mol Microbiol (2003) 2.12

MyD88 primes macrophages for full-scale activation by interferon-gamma yet mediates few responses to Mycobacterium tuberculosis. J Exp Med (2003) 2.10

The Mycobacterium tuberculosis regulatory network and hypoxia. Nature (2013) 2.04

Serogroup conversion of Vibrio cholerae in aquatic reservoirs. PLoS Pathog (2007) 1.98

Epithelial mucin stores are increased in the large airways of smokers with airflow obstruction. Chest (2006) 1.98

A distinctive alveolar macrophage activation state induced by cigarette smoking. Am J Respir Crit Care Med (2005) 1.96

Systematic genetic nomenclature for type VII secretion systems. PLoS Pathog (2009) 1.96

RpoS controls the Vibrio cholerae mucosal escape response. PLoS Pathog (2006) 1.87

igr Genes and Mycobacterium tuberculosis cholesterol metabolism. J Bacteriol (2009) 1.82

Hypoxia: a window into Mycobacterium tuberculosis latency. Cell Microbiol (2009) 1.82

In vitro susceptibility to rhinovirus infection is greater for bronchial than for nasal airway epithelial cells in human subjects. J Allergy Clin Immunol (2009) 1.78

Identification and characterization of RbmA, a novel protein required for the development of rugose colony morphology and biofilm structure in Vibrio cholerae. J Bacteriol (2006) 1.74

Silencing Mycobacterium smegmatis by using tetracycline repressors. J Bacteriol (2007) 1.66

The DosR Regulon Modulates Adaptive Immunity and Is Essential for Mycobacterium tuberculosis Persistence. Am J Respir Crit Care Med (2015) 1.63

Biosynthesis and recycling of nicotinamide cofactors in mycobacterium tuberculosis. An essential role for NAD in nonreplicating bacilli. J Biol Chem (2008) 1.62

Identification of Mycobacterial genes that alter growth and pathology in macrophages and in mice. J Infect Dis (2007) 1.60

TB database 2010: overview and update. Tuberculosis (Edinb) (2010) 1.59

Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells. Atherosclerosis (2005) 1.59

Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4. Proc Natl Acad Sci U S A (2003) 1.56

Depletion of antibiotic targets has widely varying effects on growth. Proc Natl Acad Sci U S A (2011) 1.54

The response of mycobacterium tuberculosis to reactive oxygen and nitrogen species. Front Microbiol (2011) 1.53

The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection. J Clin Invest (2011) 1.50

Acid-susceptible mutants of Mycobacterium tuberculosis share hypersusceptibility to cell wall and oxidative stress and to the host environment. J Bacteriol (2008) 1.46

The extracellular nuclease Dns and its role in natural transformation of Vibrio cholerae. J Bacteriol (2008) 1.45

Mycobacterial nonhomologous end joining mediates mutagenic repair of chromosomal double-strand DNA breaks. J Bacteriol (2007) 1.42

Improved tetracycline repressors for gene silencing in mycobacteria. Nucleic Acids Res (2009) 1.41

A genetic strategy to identify targets for the development of drugs that prevent bacterial persistence. Proc Natl Acad Sci U S A (2013) 1.39

A blind deconvolution approach to high-resolution mapping of transcription factor binding sites from ChIP-seq data. Genome Biol (2009) 1.39

Central carbon metabolism in Mycobacterium tuberculosis: an unexpected frontier. Trends Microbiol (2011) 1.36

Genomic and phenotypic diversity of coastal Vibrio cholerae strains is linked to environmental factors. Appl Environ Microbiol (2007) 1.34

Virulence of Mycobacterium tuberculosis depends on lipoamide dehydrogenase, a member of three multienzyme complexes. Cell Host Microbe (2011) 1.34

Phage offer a real alternative. Nat Biotechnol (2004) 1.32

A bistable switch and anatomical site control Vibrio cholerae virulence gene expression in the intestine. PLoS Pathog (2010) 1.32

Identification of new drug targets and resistance mechanisms in Mycobacterium tuberculosis. PLoS One (2013) 1.31

Evaluating the sensitivity of Mycobacterium tuberculosis to biotin deprivation using regulated gene expression. PLoS Pathog (2011) 1.29

Characterization of a Clp protease gene regulator and the reaeration response in Mycobacterium tuberculosis. PLoS One (2010) 1.28

Structures of Mycobacterium tuberculosis DosR and DosR-DNA complex involved in gene activation during adaptation to hypoxic latency. J Mol Biol (2005) 1.26

Detection and transformation of genome segments that differ within a coastal population of Vibrio cholerae strains. Appl Environ Microbiol (2007) 1.23

The epithelial anion transporter pendrin is induced by allergy and rhinovirus infection, regulates airway surface liquid, and increases airway reactivity and inflammation in an asthma model. J Immunol (2008) 1.21

Crystal structures of the response regulator DosR from Mycobacterium tuberculosis suggest a helix rearrangement mechanism for phosphorylation activation. J Mol Biol (2008) 1.20

Alveolar epithelial cells express mesenchymal proteins in patients with idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol (2011) 1.16

Database resources for the tuberculosis community. Tuberculosis (Edinb) (2013) 1.16

Novel Saccharomyces cerevisiae screen identifies WR99210 analogues that inhibit Mycobacterium tuberculosis dihydrofolate reductase. Antimicrob Agents Chemother (2002) 1.16

Simultaneous analysis of multiple Mycobacterium tuberculosis knockdown mutants in vitro and in vivo. PLoS One (2010) 1.14

Immune complex-dependent remodeling of the airway vasculature in response to a chronic bacterial infection. J Immunol (2005) 1.14

Pathway profiling in Mycobacterium tuberculosis: elucidation of cholesterol-derived catabolite and enzymes that catalyze its metabolism. J Biol Chem (2011) 1.13

Pathway-selective sensitization of Mycobacterium tuberculosis for target-based whole-cell screening. Chem Biol (2012) 1.13

Stabilization of mutant BRCA1 protein confers PARP inhibitor and platinum resistance. Proc Natl Acad Sci U S A (2013) 1.11

The type IV pilus assembly complex: biogenic interactions among the bundle-forming pilus proteins of enteropathogenic Escherichia coli. J Bacteriol (2002) 1.11

Expression profiling of host pathogen interactions: how Mycobacterium tuberculosis and the macrophage adapt to one another. Microbes Infect (2006) 1.11

Role of cholesterol in Mycobacterium tuberculosis infection. Indian J Exp Biol (2009) 1.11

Biofilm acts as a microenvironment for plankton-associated Vibrio cholerae in the aquatic environment of Bangladesh. Microbiol Immunol (2007) 1.11

Nitrate respiration protects hypoxic Mycobacterium tuberculosis against acid- and reactive nitrogen species stresses. PLoS One (2010) 1.11

Increased DNA microarray hybridization specificity using sscDNA targets. BMC Genomics (2005) 1.09

The Mycobacterium tuberculosis complex transcriptome of attenuation. Tuberculosis (Edinb) (2004) 1.08

Bisubstrate adenylation inhibitors of biotin protein ligase from Mycobacterium tuberculosis. Chem Biol (2011) 1.08

Mycobacterium tuberculosis virulence: lipids inside and out. Nat Med (2007) 1.07

B lymphocytes promote lymphogenous metastasis of lymphoma and melanoma. Neoplasia (2011) 1.06

Dynamic contrast-enhanced magnetic resonance imaging of tumor-induced lymph flow. Neoplasia (2008) 1.06

Relationship between kinetic stability and immunogenicity of HLA-DR4/peptide complexes. Eur J Immunol (2002) 1.05

Controlling gene expression in mycobacteria. Future Microbiol (2006) 1.05

Comparative analysis of Mycobacterium and related Actinomycetes yields insight into the evolution of Mycobacterium tuberculosis pathogenesis. BMC Genomics (2012) 1.05

Trafficking of superinfecting Mycobacterium organisms into established granulomas occurs in mammals and is independent of the Erp and ESX-1 mycobacterial virulence loci. J Infect Dis (2008) 1.04

Protein inactivation in mycobacteria by controlled proteolysis and its application to deplete the beta subunit of RNA polymerase. Nucleic Acids Res (2010) 1.03

High-throughput screening and sensitized bacteria identify an M. tuberculosis dihydrofolate reductase inhibitor with whole cell activity. PLoS One (2012) 1.03